HIGHLIGHTS
- who: Hyoeun Kim from the Department Yonsei University have published the article: Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis, in the Journal: Scientific Reports Scientific Reports
- what: The authors demonstrated that patients with HFrEF initiated on a VLD of SV were characterized by lower SBP, BMI, and LVEF at baseline. This study showed that very low doses of SV (12/13 to 24/26 mg daily) were prescribed.
SUMMARY
Patients were stratified according to the dose of SV as follows; patients in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.